{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:03:32Z","timestamp":1756339412866,"version":"3.44.0"},"reference-count":17,"publisher":"BMJ","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DTB"],"published-print":{"date-parts":[[1994,10]]},"abstract":"<jats:p>Two fluoroquinolone antibiotics, ciprofloxacin (Ciloxan - Alcon) and ofloxacin (Exocin - Allergan), are available in the UK as topical preparations for the eye.* Ciprofloxacin eyedrops are licensed for the treatment of \"corneal ulcers and superficial infections of the eye\", and ofloxacin eyedrops for \"external ocular infections (such as conjunctivitis and keratoconjunctivitis)\". In the UK chloramphenicol is commonly recommended as the drug of first choice for the treatment of superficial bacterial eye infections.1<jats:sup>,<\/jats:sup>2 Do fluoroquinolone preparations offer any advantage over this or other established drugs?<\/jats:p>","DOI":"10.1136\/dtb.1994.321078","type":"journal-article","created":{"date-parts":[[2007,10,19]],"date-time":"2007-10-19T11:44:20Z","timestamp":1192794260000},"page":"78-79","source":"Crossref","is-referenced-by-count":0,"title":["Fluoroquinolones for the eye"],"prefix":"10.1136","volume":"32","member":"239","published-online":{"date-parts":[[1994,10,1]]},"reference":[{"key":"2025082702171392000_32.10.78.1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/dtb.26.11.43","article-title":"Polytrim eyedrops","volume":"26","year":"1988","journal-title":"DTB"},{"key":"2025082702171392000_32.10.78.2","unstructured":"British National Formulary 1994."},{"key":"2025082702171392000_32.10.78.3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1136\/dtb.31.18.69","article-title":"Fluoroquinolones reviewed","volume":"31","year":"1993","journal-title":"DTB"},{"key":"2025082702171392000_32.10.78.4","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/22.Supplement_C.9"},{"key":"2025082702171392000_32.10.78.5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2165\/00003495-199300453-00006","article-title":"The epidemiology of bacterial resistance to quinolones","volume":"45","author":"Acar","year":"1993","journal-title":"Drugs"},{"key":"2025082702171392000_32.10.78.6","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1007\/BF01793579","article-title":"Bacterial resistance of fluoroquinolones: lessons to be learned","volume":"2","author":"Ball","year":"1994","journal-title":"Infection"},{"key":"2025082702171392000_32.10.78.7","doi-asserted-by":"crossref","first-page":"S960","DOI":"10.1093\/clinids\/11.Supplement_5.S960","article-title":"Bacterial resistance to quinolones: mechanisms and clinical importance","volume":"11","author":"Wolfson","year":"1989","journal-title":"Rev Infect Dis"},{"key":"2025082702171392000_32.10.78.8","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0002-9394(14)71801-X","article-title":"Ciprofloxacin-resistant bacterial keratitis","volume":"114","author":"Snyder","year":"1992","journal-title":"Am J Ophthalmol"},{"key":"2025082702171392000_32.10.78.9","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1976.03910040521010"},{"key":"2025082702171392000_32.10.78.10","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0022-3476(84)80566-1","article-title":"Efficacy of topical antibiotic therapy in acute conjunctivitis in children","volume":"104","author":"Gigliotti","year":"1984","journal-title":"J Pediatr"},{"key":"2025082702171392000_32.10.78.11","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.75.11.675"},{"key":"2025082702171392000_32.10.78.12","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.76.12.714"},{"key":"2025082702171392000_32.10.78.13","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1992.01080210052022"},{"key":"2025082702171392000_32.10.78.14","first-page":"29","article-title":"Antimicrobial effectiveness of ciprofloxacin 0.3% ophthalmic solution in the treatment of bacterial conjunctivitis","volume":"112","author":"Leibowitz","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"2025082702171392000_32.10.78.15","first-page":"34","article-title":"Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis","volume":"112","author":"Leibowitz","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"2025082702171392000_32.10.78.16","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0002-9394(14)74449-6","article-title":"Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of ulcerative keratitis","volume":"115","author":"Parks","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"2025082702171392000_32.10.78.17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/112067219300300205","article-title":"Evaluation of efficacy and safety of ciprofloxacin ophthalmic solution versus chloramphenicol","volume":"3","author":"Power","year":"1993","journal-title":"Eur J Ophthalmol"}],"container-title":["Drug and Therapeutics Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/dtb.1994.321078","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T09:17:24Z","timestamp":1756286244000},"score":1,"resource":{"primary":{"URL":"https:\/\/dtb.bmj.com\/lookup\/doi\/10.1136\/dtb.1994.321078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,10]]},"references-count":17,"journal-issue":{"issue":"10","published-online":{"date-parts":[[1994,10,1]]},"published-print":{"date-parts":[[1994,10]]}},"alternative-id":["10.1136\/dtb.1994.321078"],"URL":"https:\/\/doi.org\/10.1136\/dtb.1994.321078","relation":{},"ISSN":["0012-6543","1755-5248"],"issn-type":[{"type":"print","value":"0012-6543"},{"type":"electronic","value":"1755-5248"}],"subject":[],"published":{"date-parts":[[1994,10]]}}}